The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1143
November 11, 2002
View Complete Issue         Table of Contents 2019 
Potassium Iodide for Thyroid Protection in a Nuclear Accident or Attack
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Potassium Iodide for Thyroid Protection in a Nuclear Accident or Attack
November 11, 2002 (Issue: 1143)
Potassium iodide (KI) taken orally before or at the time of exposure can limit or prevent uptake of radioactive iodine by the thyroid gland. Children, adolescents and young adults who as children were exposed to even small amounts of radioiodine from...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Potassium Iodide for Thyroid Protection in a Nuclear Accident or Attack
Article code: 1143c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.